Objective: The aim of this study is to identify the risk factors in relation to survival of patients with small cell carcinoma of the upper urinary tract (UUT-SCC). Methods: Literature search on UUT-SCC was performed in databases including MEDLINE, EMBASE, Wanfang, and CNKI. Studies were eligible for inclusion if outcomes of patients with histopathologically confirmed UUT-SCC were reported. The relevant data on clinic, pathology, and therapy were collected. Progress survival was evaluated using the Cox regression model with the robust sandwich estimates of the covariance matrix. Results: There were 55 eligible publications identified, contributing 76 patients in total. The median of overall survival (OS) was 14 months. In univariable analyses, pathological stage and platinum-based chemotherapy regimen were associated with OS (pT3-pT4 vs. pT1-pT2, HRs =3.228, P=0.005; other chemotherapies vs. platinumbased, HRs =6.249, P=0.035). The median of cancerspecific survival (CSS) was 15 months. In univariable analyses, pathological stage and platinum-based chemotherapy regimen were associated with CCS (pT3-pT4 vs. pT1-pT2, HRs =3.332, P=0.004; non-platinum based vs. platinum-based, HRs =7.784, P=0.025). In multivariable analyses, no variables were associated with OS and CSS. Conclusions: UUT-SCC is a rare tumor characterized by an aggressive clinical course. Pathological stage and platinum-based chemotherapy regimen are the most important factors related to OS and CSS. Cite this abstract as: Shen Z, Wu H. Small Cell carcinoma of the upper urinary tract and factors associated with progress survival: a systematic review and pooled analysis.
Objective: To investigate the clinicopathological significance of Lymphovascular invasion in the ureteral transitional cell carcinoma after radical nephroureterectomy (RNU). Methods: Retrospective review of 29 ureteral transitional cell carcinoma patients with lymphovascular invasion from January 2006 to December 2012 at our hospital was performed, and another 58 patients were matched as negative control in terms of gender, age, pathological staging, grading and pattern. All the data were calculated by using SPSS 20.0 software. The Kaplan-Meier method was used to calculate overall survival and recurrence-free survival, and differences were assessed with the Log-rank statistic. Results: Twelve patients died after a median follow-up of 36.76 months in the LVI group, and 7 patients died after a median follow-up of 41.60 months in the control group. The 1-year, 3-year and 5-year survival rates in LVI group were 93.0%, 68.2%, 49.2%, and in the control group were 98.2%, 91.9%, 81.8%. There were statistically significant differences of the total survival in the two groups (X 2 =8.695, P=0.003). Seventeen patients recurrence in the LVI group, and 12 patients in the control group. There were statistically significant differences of the recurrence-free survival in the two groups (X 2 =14.452, P<0.001).
Conclusions:
In the ureteral transitional cell carcinoma patients after RNU, LVI led to the poor prognosis of the cancer, and this finding has important significance for the following-up and therapy. Objective: To explore the clinical, pathology, and prognosis of sarcomatoid carcinoma of the renal pelvis. Methods: A case of the diagnosis and treatment of sarcomatoid carcinoma of the renal pelvis in our hospital were retrospectively analyzed. Articles were searched from the full-text databases, such as NCBI and PUBMED, the dates of clinical and pathology was collected from the satisfied articles, the feature of clinical, pathology and prognosis were summarized. Results: Thirty-nine articles were screened, after screening, only 15 articles met the inclusion criteria, total 32 cases were included, combined with our center, 33 cases were included in the final analyzed. Most patients with sarcomatoid carcinoma of the renal pelvis are diagnosed because of abdominal pain and hematuria, most of them pathology ≥T2, according to the TNM classification system, most of the patients have radical prostatectomy. According to univariable Cox model, Not yet considered whether the impact of the prognosis of patients with follow-up treatment of the patients, 6 cases were recurrence, The median time to recurrence was three months, a total of 13 patients died, with a median time to death was seven months. Univariate analysis showed that patients' gender, age, region, metastasis, tumor size, pathological stage has no effect on the prognosis of patients.
Most likely resulting from the advanced stage of the disease at diagnosis and a poor response to systemic therapy. The present analysis suggests a poor prognosis for the majority of sarcomatoid carcinoma of the renal pelvis patients. To improve the survival rate of RPSC, it is therefore essential to perform an early diagnosis and early radical surgery. Objectives: Laparoscopic nephropexy has been reported as a minimally invasive approach for symptomatic nephroptosis. We performed five cases of laparoscopic nephropexy using a self-made polytetrafluoroethylene "basket" to fix the inferior parts of kidneys to 12 th rib. Methods: All patients (four women and one man) had symptomatic nephroptosis presenting with flank pain, repeat hemoturine or hydronephrosis. Preoperative ultrasonography, intravenous urography and renal CT scan in supine and upright positions were done for nephroptosis diagnosis. Transperitoneal laparoscopic nephropexy were carried out using self-prepared "basket" made of stripes cutting from polytetrafluoroethylene herniorrhaphy mesh.
After the kidney was completely dissected from surrounding
